We analyze the timing of neural patterning in Xenopus and the mechanism by which the early pattern is generated. With regard to timing, we show that by early gastrula, two domains of the anteroposterior (A/P) pattern exist in the presumptive neurectoderm, since the opl gene is expressed throughout the future neural plate, while the fkh5 gene is expressed only in more posterior ectoderm. By mid-gastrula, this pattern has become more elaborate, with an anterior domain de®ned by expression of opl and otx2, a middle domain de®ned by expression of opl and fkh5, and a posterior domain de®ned by expression of opl, fkh5 and HoxD1. Explant assays indicate that the late blastula dorsal ectoderm is speci®ed as the anterior domain, but is not yet speci®ed as middle or posterior domains. With regard to the mechanism by which the A/P pattern is generated, gain and loss of function assays indicate that quantitatively and qualitatively different factors may be involved in inducing the early A/P neural pattern. These data show that neural patterning occurs early in Xenopus and suggest a molecular basis for initiating this pattern. q
Introduction
In vertebrates, the dorsal ectoderm becomes determined as neurectoderm and patterned along the anteroposterior (A/P) axis during gastrulation. In amphibians, this was initially shown using explant and transplant assays. For example, dorsal ectoderm (presumptive neurectoderm) from a mid-gastrula embryo will form a secondary neural plate when transplanted to the ventral side of the embryo, and when explanted will differentiate into neurons (Jones and Woodland, 1989; Sive et al., 1989; Spemann, 1938) . One limitation of such studies was their inability to directly visualize the pattern within the presumptive neural plate at the time the assay was initiated, since between the time of transplant or explant and the analysis of tissue fate, an unstable pattern may have been lost or altered.
The isolation of marker genes expressed during gastrulation is beginning to allow direct visualization of the developing neural pattern. A limited set of genes that show patterned expression in the neurectoderm at mid-gastrula has been characterized in Xenopus. These include otx2 (Blitz and Cho, 1995; Pannese et al., 1995) which marks the anterior neurectoderm (presumptive forebrain) and HoxD1 (Kolm and Sive, 1995) which marks more posterior neurectoderm (the presumptive hindbrain and spinal cord). Although neural determination and patterning has occurred by mid-gastrula, the A/P pattern present at this time is easily perturbed (Saha and Grainger, 1992; Sive et al., 1989 Sive et al., , 1990 . At early gastrula, no stable neural determination is apparent, since presumptive neurectoderm transplanted or explanted at this stage goes on to differentiate as epidermis (Jacobson and Rutishauser, 1986; Jones and Woodland, 1989; Sive et al., 1989) . It has therefore been concluded that neural induction and patterning begins between early and mid-gastrula.
The A/P pattern in the neurectoderm requires inducing signals from the adjacent and underlying mesoderm (reviewed in Harland and Gerhart, 1997; Gamse and Sive, 2000) . Two models have been proposed to explain how the neurectodermal pattern is induced. The one-to-one or qualitative model proposed that by late gastrula, each different A/P position in the neurectoderm was induced by different signals sent by the corresponding region in the underlying mesendoderm (discussed in Gamse and Sive, 2000) . However, this model could not account for the dynamic nature of A/P patterning and the movement of the mesendoderm during gastrulation. The two-signal model, originally proposed by Nieuwkoop (discussed in Slack and Tannahill, 1992; Gamse and Sive, 2000) , suggests that ectoderm is initially induced as presumptive neurectoderm of uniform anterior character (forebrain) by an anterior (`activation') signal. Subsequently, a posteriorizing (`transformation') signal modi®es some of this tissue to become hindbrain and spinal cord, but is not able to induce neural identity in naive tissue. The model does not explicitly account for regionalization of the forebrain, which could result from either a single anterior inducer acting in a graded fashion, or from multiple anterior inducers.
Several factors which can induce anterior neural tissue, and thus have the characteristics of`activators', have been identi®ed. These include Noggin and Chordin, which are expressed in dorsal mesoderm and block the ventralizing action of bone morphogenetic proteins (BMPs) (Piccolo et al., 1996; Zimmerman et al., 1996) . In isolated ectoderm, Noggin and Chordin act in a graded fashion to activate expression of genes characteristic of different positions along the mediolateral axis of the neural tube (Knecht and Harland, 1997; Wilson et al., 1997) . Additionally, Cerberus and Dickkopf are expressed in head endoderm and can induce ectopic heads upon ventral misexpression (Bouwmeester et al., 1996; Glinka et al., 1997) . Wnt proteins have also been proposed to be general neural inducers (Baker et al., 1999) , while ®broblast growth factor (FGF) can in some assays have general neural-inducing character (Kengaku and Okamoto, 1995; Lamb and Harland, 1995) .
Molecules with the characteristics of`transformers' include retinoic acid (RA), which can activate expression of genes normally expressed in the posterior neural tube in blastula ectoderm, and can downregulate expression of anterior ectodermal markers (Durston et al., 1989; Sive et al., 1990) . Inhibition of RA signaling disturbs hindbrain and spinal cord induction (Blumberg et al., 1997; . Wnt proteins, particularly Wnt8 and Wnt3a, can activate expression of posterior marker genes (Bang et al., 1999; McGrew et al., 1995 McGrew et al., , 1997 , and prevent activation of anterior neural marker gene expression in isolated ectoderm (Fredieu et al., 1997) . A truncated Xwnt8 protein that partially blocks Wnt signaling has the opposite effect, preventing activation of posterior marker gene expression in neuralized ectoderm (Bang et al., 1999) . Finally, FGF has also been proposed to be a posteriorizing molecule (Cox and Hemmati-Brivanlou, 1995; Holowacz and Sokol, 1999; Kengaku and Okamoto, 1995; Lamb and Harland, 1995) .
In order to de®ne early events that occur during A/P neural patterning, we have analyzed the timing of expression and regulation of several early neural markers. We show that the expression of two of these markers, opl and fkh5, de®nes an A/P pattern in the presumptive neurectoderm at early gastrula, and that this pattern becomes more complex during gastrulation. Possible mechanisms for generating the early neural A/P pattern are suggested.
Results

fkh5 is a winged helix transcription factor expressed during gastrulation
The Xenopus homolog of fkh5 was isolated in a subtractive cloning screen to identify genes active in the presumptive neurectoderm at mid-gastrula (Kuo et al., 1998; Patel and Sive, 1996) . One clone isolated was a fragment of a fkh/ HNF-3b DNA binding protein, which was used to isolate a full-length cDNA clone that encoded a forkhead domain protein (GenBank accession number AF064810). This cDNA included an open reading frame encoding a protein of 320 amino acids containing a forkhead (fkh) DNA binding domain at its N-terminus. The forkhead domain of this gene was identical to the partial Xenopus genomic clone XFD-5 (Kno Èchel et al., 1992) , and closely resembled that of mouse forkhead-5 (Ang et al., 1993; Kaestner et al., 1993 Kaestner et al., , 1996 Sasaki and Hogan, 1993) , and zebra®sh forkhead-5 (Grinblat et al., 1998 ) (96% identity to both at the amino acid level). Xenopus fkh5 was well conserved outside of the fkh domain as well, showing 83% identity to mouse and 70% identity to zebra®sh fkh5 over the entire protein. On the basis of these data, we believe that this is the Xenopus homolog of fkh5, and have named this gene accordingly.
fkh5 is expressed in posterior neurectoderm during gastrulation
In order to ask whether fkh5 was a useful marker of the early Xenopus A/P neural pattern, we performed Northern analysis and whole-mount in situ hybridization. By Northern analysis, expression of fkh5 began at early gastrula, peaked at mid-gastrula and remained detectable until late tailbud stages (Fig. 1A) .
By in situ hybridization, fkh5 expression was detectable at the onset of gastrulation (stage 101; this and all staging according to Nieuwkoop and Faber, 1994) (Fig. 2B) ; at this stage and at early gastrula (stage 10.5) (Fig. 1Ba) , expression was in the posterior dorsal ectoderm and non-involuted mesoderm as determined by double in situ hybridization with Xbra (data not shown). fkh5 RNA was not present in involuted mesoderm and was restricted to the sensorial (inner) layer of the ectoderm (Fig. 1Bb) . By mid-gastrula (stage 11.5), fkh5 expression was solely in the posterior ectoderm (based on double in situs with Xbra, data not shown) and was not as strong in the midline as it was more laterally (Fig. 1Bc,d ). At the end of gastrulation (stage 13), strong fkh5 expression was present in regions fated to become diencephalon, midbrain, and hindbrain, and was more weakly expressed in regions fated to become spinal cord and tailbud (Fig. 1Be) . All expression was restricted to the ectoderm (Fig. 1Bf) . At late neurula (stage 17±18), fkh5 was expressed in two bands anteriorly (Fig. 1Bg, arrows) , and remained at low levels more posteriorly. In anterior cross-sections of this stage, fkh5 was expressed in the ventral and lateral neural folds, but not in the most dorsal portions (Fig. 1Bh, bracket) ; more posteriorly, expression was restricted to the ventral neural folds (Fig. 1Bi, bracket) . At tailbud (stage 29±30), expression of the two anterior bands was maintained, and expression was detectable along the length of the central nervous system (CNS) and in the tailbud (Fig. 1Bj) .
Double in situ hybridization of fkh5 with other marker genes at neurula stages revealed the positional identity of the two bands which strongly express fkh5. The anterior region of fkh5 expression abutted and extended anteriorly to the midbrain/hindbrain boundary as marked by en2 expression (Fig. 1Bo,p, bracket) . This region correlates with the area fated to become diencephalon and mesencephalon at stage 15 (Eagleson and Harris, 1990) . This anterior region of fkh5 expression also overlapped the forebrain/ midbrain marker otx2 (Fig. 1Bk ,l, arrowhead), but did not extend as far anteriorly as that of opl, which marks the anterior neural plate including the telencephalon at this opl is expressed in all three domains. otx2 expression is primarily restricted to the anterior domain, with lower expression in the midline of the middle domain. fkh5 expression is seen in middle and posterior domains. HoxD1 is expressed in the posterior domain only. stage (Fig. 1Bm,n) (Kuo et al., 1998; Mizuseki et al., 1998) . This shows that the anterior stripe of fkh5 expression was in the midbrain and posterior forebrain (diencephalon) but did not extend into the more anterior forebrain (telencephalon). The more posterior strong band of fkh5 expression co-localized with the rhombomere 5 stripe of the hindbrain marker krox-20 (Fig. 1Bo,p, arrowhead) .
In summary, fkh5 is a marker of posterior dorsal ectoderm during gastrulation, and is later expressed in the diencephalon of the forebrain, as well as midbrain, hindbrain and spinal cord.
Neural patterning begins at the onset of gastrulation
Since fkh5 was expressed in the presumptive neurectoderm very early during gastrulation, we used this marker in comparison with another early neural-speci®c marker, opl (Kuo et al., 1998) to ask whether an A/P pattern was present early during gastrulation. We also compared expression of fkh5 and opl to that of two other early neural markers: otx2, a marker of presumptive forebrain and midbrain (Blitz and Cho, 1995; Pannese et al., 1995) and HoxD1, a marker of presumptive hindbrain and spinal cord (Kolm and Sive, 1995; Sive and Cheng, 1991) .
At stage 101 (onset of gastrulation), strong opl expression was observed throughout the dorsal ectoderm. fkh5 expression was restricted to posterior dorsal tissue (both ectoderm and mesoderm, based on double in situ hybridization with Xbra, data not shown) ( Fig. 2A,B) . Expression of otx2 and HoxD1 was not detectable. By stage 10.5 (early gastrula), opl and fkh5 were expressed in approximately the same relative positions as they were at stage 101 (Fig.  2C,D) . At this stage, low levels of otx2 RNA were present in the posterior midline ectoderm (Fig. 2E ) (Blitz and Cho, 1995; Pannese et al., 1995) , and HoxD1 expression had begun in the posterior lateral ectoderm (Fig. 2F) (Kolm and Sive, 1995) . By stage 11.5 (mid-gastrula), all four markers analyzed were expressed in the presumptive neurectoderm. opl continued to be expressed throughout the dorsal ectoderm (Fig. 2G) , with fkh5 expression more posteriorly (Fig. 2H ), otx2 expression primarily in an anterior domain with some midline expression more posteriorly (Fig. 2I) , and HoxD1 expression in posterolateral ectoderm (Fig. 2J ).
In conjunction with opl which is expressed throughout the presumptive neurectoderm, these patterns of gene expression de®ne anterior, middle, and posterior (A, M, and P) domains in the presumptive neurectoderm at mid-gastrula (Fig. 2K,L) . The anterior domain is de®ned by expression of otx2 and the absence of fkh5 or HoxD1 expression, the middle domain is de®ned by fkh5 expression (as well as a small amount of midline otx2 expression) and the absence of HoxD1 expression, while the posterior domain expresses fkh5 and HoxD1, but not otx2.
Thus, by the onset of gastrulation the presumptive neurectoderm contains two domains of gene expression, and three domains by mid-gastrula. Comparison of gene expression patterns to published fate maps at early gastrula suggests that opl and fkh5 expression may divide the domain fated to become forebrain/midbrain (Keller, 1975; Keller et al., 1992) .
2.4. Expression of some ectodermal markers is speci®ed at mid-blastula, and begins at late blastula
We next asked when expression of markers whose expression is restricted to the presumptive neurectoderm was speci®ed. We use the term speci®cation to mean that an isolated (explanted) tissue which does not express a particular marker gene at the time of explant goes on to activate expression of that gene during an in vitro culture period (Slack, 1991) . We previously showed that opl is expressed throughout the ectoderm at stage 9.5 (Kuo et al., 1998) , and asked when expression of this and other ectodermal markers was speci®ed in ectodermal explants. Ectoderm (animal caps) was isolated from mid-blastula stage embryos (stage 8), and either harvested immediately or aged until control embryos reached late blastula (stage 9.5), or removed at stage 9.5 and harvested immediately (Fig. 3A) . Gene expression was analyzed by a reverse transcriptase-PCR (RT-PCR)-based assay (see Section 4). Markers used were opl, fkh5, otx2, and Xanf1 (later, an anterior neural marker) (Zaraisky et al., 1992) , and the markers BMP4 (Fainsod et al., 1994; Schmidt et al., 1995) , Vent-1 (Ault et al., 1996; Gawantka et al., 1995) , and Vox-1 (Onichtchouk et al., 1996; Schmidt et al., 1996) which are later expressed ventrally, but at the stages assayed here are expressed throughout the animal cap.
None of the markers analyzed were expressed at stage 8 (Fig. 3B , lane 1). In contrast, in caps cut and harvested at stage 9.5, opl, Xanf1, BMP4 and Vox-1 were all expressed, while expression of fkh5, otx2 and Vent-1 was not detectable (Fig. 3B , lane 2). In a speci®cation assay, caps removed at stage 8 and aged until stage 9.5 went on to express opl, Xanf1, BMP4 and Vox-1 (Fig. 3B , lane 3); that is, stage 8 caps were speci®ed to express these genes. fkh5 expression was also weakly speci®ed in aged stage 8 ectoderm (Fig. 3B , lane 3), although it was not expressed in intact stage 9.5 embryos. This was a surprising but reproducible result. One interpretation is that ectodermal expression of fkh5 is normally repressed by signals from other parts of the embryo, and isolated ectoderm is removed from this repression. In contrast, expression of neither otx2 nor Vent-1 was speci®ed in stage 8 ectoderm. Xbra, a control for mesodermal contamination, was not expressed at any time analyzed, while some MyoD RNA was present, as previously described (Rupp and Weintraub, 1991) .
In summary, these data reveal that blastula ectoderm expresses markers whose RNA is either later restricted to the neurectoderm or to ventral regions of the embryo. This was demonstrated by speci®cation for expression of these markers at mid-blastula (stage 8) and the activation of their expression by late blastula (stage 9.5). These analyses did not indicate whether speci®cation of these markers was restricted to dorsal or ventral regions of the mid-blastula cap.
Expression of otx2 is speci®ed in dorsal ectoderm by late blastula
We extended the assays from the previous section to ask whether markers whose expression is later restricted to the neurectoderm were speci®ed dorsally but not ventrally in late blastula ectoderm (stage 9.5). Experiments were not performed at mid-blastula as it is dif®cult to accurately separate dorsal and ventral ectoderm at this stage. We also asked whether marker genes already expressed at early gastrula (stage 10.5) were stably expressed in explanted tissue (Fig. 4A) . Markers of the presumptive neurectoderm examined were opl, otx2, and fkh5, as well as the ectodermal marker BMP4, with Xbra as a control for mesodermal contamination. In order to accurately identify dorsal and ventral ectoderm from late blastula stage we used the`tip and stain' method which allows accurate positioning of the future dorsal side of the embryo before the blastopore landmark is visible .
In the ®rst set of assays, late blastula (stage 9.5) dorsal or ventral ectoderm was explanted and either harvested immediately or cultured until control embryos reached early gastrula (stage 10.5) (Fig. 4A ). Dorsal and ventral ectoderm harvested at stage 9.5 expressed opl and BMP4 RNAs at equal levels (Fig. 4B , lanes 1 and 2), while expression of otx2 and fkh5 was not detected. In stage 9.5 ectoderm cultured until control embryos reached stage 10.5, expression of opl persisted more strongly in dorsal ectoderm than in ventral ectoderm (two-fold greater, averaged over three independent experiments), while expression of otx2 was speci®ed in dorsal but not ventral ectoderm (Fig. 4B , lanes 3 and 4). Expression of opl and otx2 in cultured stage 9.5 ectoderm was not as strong as it was in an equivalent piece of ectoderm isolated and harvested at stage 10.5 (ten-fold greater expression for each gene in stage 10.5 ectoderm), suggesting that expression of these genes must be actively maintained by signals from outside the ectoderm. Expression of fkh5 was not speci®ed in cultured stage 9.5 ectoderm, suggesting that signals from outside this region of ectoderm were required for its activation. For these experiments we attempted to remove a posterior piece of ectoderm that would later contain the fkh5 expression domain, based on the fate maps of Keller (1975) , Keller et al. (1992) , Vodicka and Gerhart (1995), and Bauer et al. (1994) . However, since we did not perform fate mapping ourselves, in parallel with the explants, we cannot be absolutely certain that a piece of tissue fated to express fkh5 was explanted. BMP4 was expressed at similar levels in cultured stage 9.5 dorsal and ventral ectoderm (Fig. 4B , compare lanes 3 and 5). Thus, at late blastula, dorsal ectoderm was speci®ed for anterior domain genes, and differently from ventral ectoderm.
In order to test the relative stability of gene expression in the anterior and middle dorsal ectodermal domains present at early gastrula (stage 10.5) ( Fig. 2A,B) , dorsal and ventral ectodermal explants were prepared from stage 10.5 embryos and either harvested immediately or cultured until control embryos reached mid-gastrula (stage 11.5). In tissue cut and harvested immediately, opl, otx2 and fkh5 were all expressed more strongly in dorsal than ventral ectoderm (Fig. 4B , lanes 5 and 6) (four-fold difference for opl at stage 10.5, eight-fold for otx2, 16-fold for fkh5, averaged over three independent experiments). After explant culture, expression of opl and otx2 persisted at higher levels in Fig. 3 . At mid-blastula, ectoderm is speci®ed to express the neural markers opl and Xanf1, as well as ectodermal markers BMP4 and Vox-1. (A) Experimental scheme. Animal caps were explanted at the indicated stage and either harvested immediately or incubated in saline and then harvested for RT-PCR analysis. (B) Expression of marker genes in animal caps. Lane 1, caps explanted and harvested at stage 8 (mid-blastula). Lane 2, caps explanted and harvested at stage 9.5 (late blastula). Lane 3, caps explanted at stage 8 and harvested at stage 9.5. opl, Xanf1, BMP4, and Vox-1 are expressed in stage 9.5 caps and are speci®ed in stage 8 caps aged to stage 9.5 equivalent. Whole embryo controls are present for comparison: lane 4, stage 8 embryo; lane 5, stage 9.5 embryo; lane 6, stage 11.5 (mid-gastrula) embryo. Pools of ten caps or four whole embryos were used. Results are representative of three experiments. dorsal than ventral ectoderm (three-fold difference for opl, 12-fold difference for otx2), while expression of fkh5 did not persist in either piece of ectoderm (Fig. 4B, lanes 7 and 8) . BMP4 expression was equal in stage 10.5 dorsal and ventral ectoderm either harvested immediately (Fig. 4B , lanes 5 and 6) or aged before harvest (Fig. 4B, lanes 7 and 8) . In contrast to the case at late blastula, levels of opl and otx2 RNA that persisted in isolated stage 10.5 dorsal ectoderm aged until stage 11.5 was equal (for otx2) or only three-fold less (for opl) to that observed in an equivalent piece of isolated stage 11.5 ectoderm (Bauer et al., 1994; Keller, 1975) (Fig. 4B,  compare lanes 7 and 9) .
In summary, these data indicate that by late blastula, the dorsal ectoderm is speci®ed to express the anterior domain marker otx2. Expression of the middle domain marker fkh5 is apparently not speci®ed at this stage; however, it is possible that some ectoderm not used in our assays is so speci®ed. At early gastrula, expression of opl and otx2 is maintained at higher levels in cultured dorsal ectoderm than in ventral ectoderm, while expression of fkh5 is not stable.
Dorsal expression of the opl and fkh genes requires dorsal axis formation
To analyze the tissue requirements for the early A/P extodermal patterning, we asked whether expression of opl and fkh5 at late blastula and gastrula stages was dependent on dorsally-derived signals. Expression was examined in embryos ventralized by treatment with ultraviolet light (UV) during the ®rst cell cycle (Scharf and Gerhart, 1980) . UV irradiation prevents the formation of dorsal mesoderm, which is required for induction of neural pattern.
As shown in Fig. 5Aa and consistent with the data shown in Fig. 4B , opl expression at stage 9.5 was uniform throughout the animal cap. This initial expression was not dependent on dorsally-derived signals, as it was unchanged in UV-treated embryos (Fig. 5b) and RT-PCR showed no difference in the level of opl RNA present in control versus UV-treated embryos at this stage (data not shown). In contrast to the results obtained at late blastula, at early gastrula ( Fig. 5c±f ) and mid-gastrula (Fig. 5g±j ) the dorsal restriction of opl expression and dorsal activation of fkh5 expression did not occur in UV-treated embryos. Thus, the uniform expression of opl in blastula stage ectoderm is unaffected by ventralization of the embryo, whereas gastrula stage dorsal restriction of opl and fkh5 expression is prevented by ventralization. Fig. 4 . Expression of the anterior marker otx2 is dorsally speci®ed at late blastula. (A) Experimental scheme. Embryos were tipped and stained to mark the dorsal side during the ®rst cell cycle (as described in Section 4). Dorsal and ventral ectoderm was explanted from stage 9.5 (late blastula) embryos and either harvested immediately for RT-PCR or incubated in saline to stage 10.5 (early gastrula) equivalent and harvested for RT-PCR. Dorsal and ventral ectoderm was explanted from stage 10.5 embryos and either harvested immediately or incubated in saline to stage 11.5 (midgastrula) equivalent and harvested for RT-PCR. Dorsal and ventral ectoderm was explanted from stage 11.5 embryos and harvested immediately for RT-PCR. (B) Expression of marker genes in dorsal and ventral ectodermal explants. Lane 1, dorsal ectoderm dissected and harvested at stage 9.5. Lane 2, ventral ectoderm dissected and harvested at stage 9.5. Lane 3, dorsal ectoderm dissected at stage 9.5 and harvested at stage 10.5 equivalent. Lane 4, ventral ectoderm dissected at stage 9.5 and harvested at stage 10.5 equivalent. Expression of opl and otx2 is stronger in dorsal pieces of aged stage 9.5 ectoderm than in ventral pieces. Lane 5, dorsal ectoderm dissected and harvested at stage 10.5. Lane 6, ventral ectoderm dissected and harvested at stage 10.5. Lane 7, dorsal ectoderm dissected at stage 10.5 and harvested at stage 11.5 equivalent. Lane 8, ventral ectoderm dissected at stage 10.5 and harvested at stage 11.5 equivalent. Expression of opl and otx2 is stronger in dorsal pieces of aged stage 10.5 ectoderm than in ventral pieces. Lane 9, dorsal ectoderm dissected and harvested at stage 11.5. Lane 10, ventral ectoderm dissected and harvested at stage 11.5. Lane 11, whole embryo harvested at stage 11.5. Xbra is a control for mesodermal contamination. A small amount of Xbra is seen in lane 9 in this experiment, but the presence of mesoderm in this sample did not affect results. The faster migration of fkh5 in lane 9 relative to lanes expressing fkh5 more weakly is a gel artifact, which we have observed not only for fkh5 but also for other genes expressed at high levels. Results are representative of three experiments. Pools of ten dorsal or ventral ectoderms were tested.
Different A/P markers are activated by different levels of noggin
Analysis of UV-treated embryos indicated that signals derived from the dorsal mesendoderm are required to activate the patterned expression of opl and fkh5. We therefore tested the activity of several candidate factors expressed in these tissues for their ability to differentially activate expression of opl, fkh5, otx2 and HoxD1. We ®rst tested the ability of different levels of the BMP antagonist Noggin to activate expression of these different A/P markers in animal caps harvested at mid-gastrula (stage 11; Fig. 6A ). Graded levels of Noggin have previously been shown to activate different markers along the mediolateral axis of the neural plate at tailbud stages (Lamb et al., 1993; Knecht and Harland, 1997; Wilson et al., 1997) .
After injection of 2.5 or 1 pg noggin RNA (Fig. 6B, lanes  1 and 2) , expression of opl, otx2, and fkh5 was activated relative to globin-injected caps (Fig. 6B , lane 5) (12-fold, 110-fold, and seven-fold, respectively). At 0.5 pg noggin (Fig. 6B, lane 3) , expression of opl and otx2 only was activated (®ve-fold and 50-fold, respectively). Although the absolute concentration of noggin that activated expression of fkh5, otx2, and opl varied slightly between experiments (n 3), expression of opl and otx2 was always activated at lower concentrations of noggin than was fkh5. HoxD1 expression was not activated at any noggin concentration tested (data not shown), indicating that posterior positions were not determined, nor was expression of Xbra, indicative of an absence of mesoderm. Similar results were obtained in three independent experiments. In caps aged to neurula stages, no expression of the more posterior neural marker engrailed was observed, nor was expression of m-actin, indicative of an absence of mesoderm (C. Merzdorf and H. Sive, unpublished data).
In summary, in isolated ectoderm, expression of opl and otx2 can be activated at lower Noggin concentrations than can expression of fkh5.
Different A/P markers are activated by different factors and factor combinations
Previous studies analyzing neural marker expression at tailbud stage have shown that both an anterior neural inducer and a posteriorizing factor are required for complete A/P marker activation (reviewed in Gamse and Sive, 2000) . We Expression of opl at stage 9.5 is unaffected by UV treatment, but dorsal localization of opl and fkh5 expression at stage 10.5 and 11.5 is prevented by UV. Embryos harvested at stage 30 equivalent showed that the UV treatment was effective, with all embryos having a dorso-anterior index of 0 or 1 (data not shown). Embryos hybridized to an opl sense probe, as a control for non-speci®c staining, showed no staining (data not shown).
wanted to investigate whether combinations of anterior and posterior inducers also co-operated during gastrula stages. Embryos were injected with RNA encoding the anterior inducers Noggin or Cerberus alone or in combination with the posteriorizing factors RA, FGF and Wnt3a either as puri®ed factors or as injected RNA. Animal caps were isolated at early gastrula and assayed when control embryos reached mid-gastrula for expression of opl, otx2, fkh5, and HoxD1 (Fig. 7A) . Quantitation for these data (representative of two to three experiments) is given in the legend to Fig. 7 .
Concentrations of noggin RNA that activated only opl and otx2 were used (Fig. 7B, lane 1) . Caps treated with RA alone expressed HoxD1 only (Fig. 7B, lane 2) , while caps treated with FGF alone expressed HoxD1 and also some Xbra RNA, which is indicative of mesoderm formation (Fig. 7B, lane 3) , as previously documented (Kolm and Fig. 6 . Noggin activates fkh5, opl, and otx2 expression in a dose-dependent fashion. (A) Experimental scheme. RNA (10 pg) was injected into the animal pole of wild-type embryos at the two-cell stage. At stage 9, animal caps were explanted and cultured to stage 11 equivalent in saline when they were harvested for RT-PCR. (B) Response of animal caps to various concentrations of noggin RNA. Appropriate amounts of globin RNA were co-injected with the noggin RNA so that each embryo received 10 pg of total RNA. Lane 1, caps from embryos injected with 2.5 pg noggin RNA and 7.5 pg globin RNA. Lane 2, 1 pg noggin RNA and 9 pg globin RNA. Lane 3, 0.5 pg noggin RNA and 9.5 pg globin RNA. Lane 4, 0.05 pg noggin RNA and 10 pg globin RNA. Lane 5, 10 pg globin RNA. Lane 6, whole embryos harvested at stage 11. opl and otx2 were more sensitive to Noggin than fkh5. Globin-injected caps are a negative control. Xbra is a control for mesodermal contamination. Results are representative of three experiments. Pools of 20±25 caps were tested. Fig. 7 . Noggin, cerberus, Wnt3a, RA, and FGF activate expression of different A/P markers by themselves or in combination. (A) Experimental scheme. RNA was injected into the animal pole of wild-type embryos at the two-cell stage. At stage 9, animal caps were explanted and cultured to stage 11 equivalent in saline when they were harvested for RT-PCR. RA treatments used 1 mM all-trans RA in saline. FGF treatment used 50 ng/ml hbFGF in saline. Another anterior inducer, dickkopf, did not activate any markers tested at concentrations between 10 and 1000 pg of RNA (data not shown), in contrast to a previous report in which animal caps were aged for longer periods of time (Glinka et al., 1998) . (B) Response of animal caps to noggin, RA, FGF, Wnt3a, and noggin combined with each factor. Numbers in parentheses indicate fold expression of marker genes compared to control globin-injected cap in lane 8. Lane 1, caps from embryos injected with 2.5 pg noggin RNA and 100 pg globin RNA (opl, 7.6£; otx2, 15.8£; fkh5, 0.4£; HoxD1, 1.0£). Lane 2, 100 pg globin RNA treated with 1 mM RA (opl, 0.7£; otx2, 1.0£; fkh5, 0.1£; HoxD1, 6.7£). Lane 3, 100 pg globin RNA treated with 50 ng/ml FGF (opl, 0.6£; otx2, 0.3£; fkh5, 0.2£; HoxD1, 6.9£). Lane 4, 100 pg Wnt3a RNA (opl, 5.3£; otx2, 1.3£; fkh5, 3.6£; HoxD1, 4.9£). Lane 5, 2.5 pg noggin RNA treated with 1 mM RA (opl, 6£; otx2, 11.3£; fkh5, 2£; HoxD1, 17.5£). Lane 6, 2.5 pg noggin RNA treated with 50 ng/ml FGF (opl, 5.5£; otx2, 8.5£; fkh5, 11£; HoxD1, 1.0£). Lane 7, 2.5 pg noggin, 100 pg Wnt3a (opl, 6.2£; otx2, 3.2£; fkh5, 4.3£; HoxD1, 4.7£). Lane 8, 100 pg globin. Lane 9, whole embryos harvested at stage 11. Globin-injected caps are a negative control. Xbra is a control for mesodermal contamination. Results are representative of three experiments. Pools of 20±25 caps were tested. (C) Response of animal caps to cerberus combined with RA, FGF, and Wnt3a. Numbers in parentheses indicate fold expression of marker genes relative to control globin-injected cap in lane 6. Lane 1, caps from embryos injected with 100 pg cerberus RNA and 100 pg globin RNA (opl, 4.5£; otx2, 8.5£; fkh5, 0.26£; HoxD1, 0.36£). Lane 2, 100 pg cerberus RNA treated with 1 mM RA (opl, 3.5£; otx2, 1.4£; fkh5, 0.21£; HoxD1, 6.1£). Lane 3, 100 pg cerberus RNA treated with 50 ng/ml FGF (opl, 3.8£; otx2, 6.6£; fkh5, 1.7£; HoxD1, 1.7£). Lane 4, 100 pg cerberus RNA and 100 pg Wnt3a RNA (opl, 9.3£; otx2, 0.7£; fkh5, 4.6£; HoxD1, 7.9£). Lane 5, 200 pg globin. Lane 6, whole embryos harvested at stage 11. Caps treated with each single factor (RA, FGF, Wnt3a) are not shown. Globin-injected caps are a negative control. Xbra is a control for mesodermal contamination. Results are representative of three experiments. Pools of 20±25 caps were tested. Sive, 1995) . Interestingly, caps overexpressing wnt3a alone (Fig. 7B, lane 4) expressed opl as well as fkh5 and HoxD1. The combination of noggin and RA was additive, since HoxD1 expression was activated, and opl and otx2 expression was not signi®cantly affected (Fig. 7B, lane 5) unlike the case in older explants where expression of otx2 is downregulated (Gammill and Sive, 1997) . A combination of noggin and FGF altered the spectrum of genes activated by either factor alone, leading to expression of fkh5 and inhibition of HoxD1 expression, with persistence of opl and otx2 expression (Fig. 7B, lane 6) . The combination of noggin and wnt3a led to a spectrum of gene expression that was essentially identical to that observed with wnt3a alone (Fig. 7B, lane 7) . This is in contrast to previous conclusions with older caps and later markers where both noggin plus wnt3a are required for posterior neural marker expression (McGrew et al., 1995) .
We next tested combinations of cerberus with posteriorizing factors. cerberus alone activated expression of opl and otx2, but not fkh5, over a concentration range of 30±1000 pg RNA injected (Fig. 7C , lane 1 and data not shown). HoxD1 expression was activated in the presence of both cerberus and RA (Fig. 7C, lane 2) . In addition, downregulation of otx2 expression was seen, unlike the case with noggin plus RA. The combination of cerberus and FGF, as with noggin, led to a change in the spectrum of genes activated, with fkh5 expression upregulated and HoxD1 expression downregulated (Fig.  7C, lane 3) . The combination of cerberus plus wnt3a led to a pattern of gene expression identical to that activated by wnt3a alone, that is expression of opl, fkh5 and HoxD1 (Fig. 7C, lane 4) , similar to the case for noggin plus wnt3a.
These data showed that by mid-gastrula, various factor combinations led to differential expression of A/P markers. While noggin and cerberus activated expression of anterior domain markers, wnt3a alone (or in combination with noggin or cerberus) and FGF in combination with noggin or cerberus favored expression of the middle domain marker fkh5. The posterior domain marker HoxD1 was activated by the single factors FGF, Wnt3a and RA. Data obtained were somewhat different from those previously reported for older explants.
FGF signaling is required for induction of fkh5
Although FGF synergized with noggin to activate fkh5 expression, this activation was accompanied by expression of a mesodermal marker (Fig. 7) , suggesting that FGF may have activated fkh5 indirectly. In order to ask whether FGF acted directly on the ectoderm to induce fkh5 expression, we performed induction experiments using animal caps expressing the dominant negative FGF receptor XFD (Amaya et al., 1991) conjugated to wild-type posterior dorsal mesoderm. We use the term induction to indicate that signals from one tissue (the inducing tissue) have passed to another tissue (the responding tissue) to activate expression of a marker gene in the responding tissue. The experimental design is shown in Fig. 8A . Animal caps were taken from embryos injected with XFD or globin RNA, and conjugated with posterior dorsal mesoderm from mid-gastrula (stage 11) embryos labeled with¯uorescein-dextran. Conjugates were aged until sibling embryos of animal cap donors reached stage 11, and analyzed for fkh5 expression by in situ hybridization, with¯uorescein-dextran visualized by antibody staining.
Representative results are shown in Fig. 8B . In conjugates with globin-injected caps (Fig. 8Ba) , expression of fkh5 was seen within nearly all caps (20/26 conjugates; numbers are the total from two independent experiments). In contrast, fkh5 expression was rarely seen in caps expressing XFD in such conjugates ( Fig. 8Bb ; 3/26 conjugates showed weak fkh5 expression, while 23/26 had no fkh5 expression). Similar experiments to test if Wnt3a is required for induction of fkh5 expression were not attempted. Preliminary testing of dnWnt8 (Hoppler et al., 1996) showed that Wnt3a signaling was not blocked at a 10:1 ratio of dnWnt8 to Wnt3a in animal caps. Bioactivity of dnWnt8 was tested by assaying the phenotype of embryos aged to tailbud stages.
Posterior dorsal mesoderm cultured alone (Fig. 8Bc) showed no fkh5 expression (20/20); neither did caps cultured alone after injection with globin (Fig. 8Bd, 35 / 35) or XFD (Fig. 8Be, 32/32 ).
These data are consistent with the direct action of FGF on the ectoderm to induce fkh5 expression, most likely in concert with a co-inducer such as noggin. We cannot distinguish whether FGF acted to induce mesoderm in the animal cap which then activated fkh5 expression; however, this seems unlikely over the short time-course of this experiment.
2.10. Anterior endoderm may not be suf®cient to induce expression of opl and otx2 in the whole embryo
In animal caps, activation of opl expression occurred at high cerberus RNA concentrations (30±1000 pg, Fig. 7 ) but not at lower RNA levels (10 pg, data not shown). opl expression was not activated by another factor secreted by the anterior endoderm, Dkk-1 (Glinka et al., 1998 ), at any concentration tested (data not shown). This raised the question of whether anterior endoderm alone is suf®cient to activate opl expression. In order to address this issue, we tested the inducing ability of anterior endoderm in an induction assay. Stage 11 (mid-gastrula) anterior mesendoderm or posterior mesoderm was conjugated with animal caps removed from late blastula (stage 9.5). Conjugates were aged until sibling embryos of animal cap donors reached stage 11, when they were harvested and analyzed by RT-PCR (Fig. 9A) . Results presented are representative of two independent experiments. Animal caps expressed low levels of opl RNA (eight-fold less than the whole embryo, when normalized to ornithine decarboxylase (ODC)), but did not express detectable amounts of the anterior mesendodermal marker cerberus or the chordomesodermal marker noggin (Fig. 9B, lane 1) . Dorsal mesoderm expressed both cerberus and noggin RNAs, as well as trace levels of opl (17-fold less than the whole embryo) (Fig. 9B, lane 2) . In contrast, anterior mesendoderm expressed cerberus RNA but only trace levels of noggin and opl RNAs (Fig. 9B, lane 3) . These trace levels of opl expression may be due to stray ectodermal cells adhering to the isolated mesendoderm. When conjugated to animal caps, dorsal mesoderm induced high levels of opl expression, to essentially whole embryo levels (Fig.  9B, lane 4) , while the anterior mesendodermal piece failed to induce opl gene expression over levels seen in unconjugated caps (Fig. 9B, compare lanes 1 and 5) .
These data indicate that signaling by anterior mesendoderm alone is insuf®cient for initial induction of an early neurectodermal marker in the intact embryo, consistent with published data (Bouwmeester et al., 1996; Bradley et al., 1996) .
Discussion
We have analyzed early steps in Xenopus neural patterning. By late blastula, an anterior domain of neural fate is speci®ed in the dorsal ectoderm, while by early gastrula, two A/P domains of gene expression are present. By midgastrula, at least three A/P domains of gene expression can be distinguished. Ectodermal explant assays suggest that the early neural pattern in the ectoderm is induced by quantitatively or qualitatively different factors. Fig. 9 . Anterior dorsal mesendoderm may be insuf®cient to induce opl expression. (A) Experimental scheme. Animal caps were isolated from stage 9.5 embryos, and conjugated with anterior dorsal mesendoderm (ADM) or posterior dorsal mesoderm (PDM) from stage 11 embryos. Conjugates were aged in saline until the animal caps reached stage 11 equivalent, when they were harvested for RT-PCR. As controls, ADM, PDM, and caps were cultured in isolation. (B) Response of animal caps to different pieces of mesoderm. Lane 1, caps alone. Lane 2, PDM alone. Lane 3, ADM alone. Lane 4, caps conjugated to PDM. Lane 5, caps conjugated to ADM. Lane 6, whole embryos harvested at stage 11. opl was induced by the nog 1 cer 1 PDM, but not by the nog 2 cer 1 ADM. Results are representative of two experiments. Pools of ten ADM or ten PDM conjugates, or ten ADMs or PDMs or caps alone were tested.
3.1. Initial activation of some markers in the blastula ectoderm is uniform, but an anterior neurectodermal domain is speci®ed at late blastula It has previously been suggested that the blastula ectoderm is a ventral tissue (Holtfreter and Hamburger, 1955; Jones and Woodland, 1986) . Our data indicate, however, that at mid-blastula, this tissue has both dorsal and ventral character, since it is speci®ed to express genes which are later either dorsal-or ventral-speci®c markers. For instance, at late blastula, expression of some genes whose expression is later restricted to dorsal or ventral regions (opl and BMP4) is uniform dorsally and ventrally. Similarly, Xanf1 which is later expressed exclusively dorsally, and Vox-1 which is later expressed exclusively ventrally, are also uniformly expressed in late blastula ectoderm (Schmidt et al., 1996; Zaraisky et al., 1995) . We have also reported a mixture of dorsal and ventral speci®cation for zebra®sh animal caps (Grinblat et al., 1998; Sagerstro Èm et al., 1996) . While it is not clear whether the unlocalized expression of these ectodermal markers has any functional signi®-cance, it is possible that genes active at this time are later able to respond more rapidly than inactive genes to inducing signals.
Despite the unlocalized expression of future dorsal and ventral markers at late blastula, our data suggest that at this stage the dorsal ectoderm has already begun to be speci®ed as anterior neurectoderm. This speci®cation is earlier than the differential neural competence at early gastrula demonstrated in previous studies (Otte and Moon, 1992; Sharpe et al., 1987) , and is consistent with the demonstration that expression of an epidermal antigen is speci®ed in only the ventral half of an animal cap explanted at late blastula (Savage and Phillips, 1989) .
3.2. The A/P pattern is apparent at early gastrula in the future neurectoderm and later becomes more complex Although patterned expression of opl and fkh5 in the presumptive neurectoderm is present by the onset of gastrulation, this tissue is not yet able to differentiate as neural tissue when isolated or transplanted ventrally (Holtfreter and Hamburger, 1955; Sharpe and Gurdon, 1990; Sive et al., 1989) . One explanation for this is that genes expressed in the presumptive neurectoderm at early gastrula could drive neurogenesis but are not yet expressed stably or at high enough levels. In support of this, we showed that fkh5 expression is not stably activated in explants at this time. Another possibility is that the full cohort of genes required for neural determination is not yet expressed. Consistent with the second hypothesis, the A/P pattern in the dorsal ectoderm becomes more complex by midgastrula, with activation of many other genes, including HoxD1 (Sive and Cheng, 1991) , Xanf1 and 2 (Mathers et al., 1995; Zaraisky et al., 1995) , neurogenin (Ma et al., 1996) , Xash3 (Zimmerman et al., 1993), and Xdll3 (Papalopulu and Kintner, 1993) .
A pattern of opl and fkh5 expression similar to that found in Xenopus is present by mid-gastrula in zebra®sh, indicating that this patterning event is evolutionarily conserved, although in contrast to Xenopus expression of these genes does not begin until mid-gastrula (Grinblat et al., 1998) . However, ectoderm isolated from early gastrula stage zebra®sh embryos is speci®ed to express these genes, with anterior ectoderm strongly speci®ed to express opl and more posterior ectoderm strongly speci®ed to express fkh5 (Grinblat et al., 1998) . Similarly, zebra®sh early gastrula stage ectoderm has differential competence anteriorly and posteriorly (Koshida et al., 1998) .
3.3. The A/P pattern in the presumptive neurectoderm may be activated by different factors and/or different factor concentrations Three mechanisms by which the early neural pattern is induced are suggested by our data. First, graded responsiveness to single factors may operate. Consistent with dose response data in animal caps, opl expression in vivo extends farther from the dorsal mesoderm (the source of Noggin) than fkh5. Previous studies have demonstrated that in ectodermal explants harvested at late neurula, markers along the mediolateral axis of the neural tube show a graded response to different Noggin concentrations (Knecht and Harland, 1997; Wilson et al., 1997) . In these assays it was not clear whether the markers examined were expressed as a primary or secondary response to Noggin. In contrast, opl and fkh5 are expressed soon after the onset of noggin or chordin expression in the embryo and represent proximal responses to these, perhaps along the early A/P axis. The suggestion that BMP antagonists may normally activate expression of opl is supported by the inhibition of opl expression by BMP4 (Mizuseki et al., 1998; J. Gamse and H. Sive, unpublished data) .
A second possibility is that qualitatively different factors control opl and fkh5 expression. This is suggested by the ability of the head inducer Cerberus to activate opl but not fkh5 expression in animal caps, although this may represent the weaker BMP antagonizing activity of Cerberus (Hsu et al., 1998) . Cerberus may act in concert with other factors such as Noggin, as our results show that mesendoderm expressing cerberus but not noggin cannot activate opl gene expression in conjugate assays. A third, related possibility is that combinations of factors are required for the early neural pattern (Fig. 10) . For example, FGF was able to activate expression of fkh5 in conjunction with low levels of Noggin or Cerberus, consistent with our conjugate data and those of Holowacz and Sokol (1999) .
In these experiments, we could not distinguish whether the change in intensity of a RT-PCR signal indicating marker expression was due to more cells expressing the gene in all explants, more explants expressing the gene or to increased expression of the gene in a few cells per explant. Future studies will address details of the patterning mechanism.
Distinction between assays performed during gastrulation and at later time-points
The time-course of our assays in animal caps, using a 4 h culture period ending at mid-gastrula, is much shorter than that used in published studies of neural patterning, where caps were often cultured for 24 h before assay (e.g. Bouwmeester et al., 1996; Lamb et al., 1993; McGrew et al., 1995) . Thus, the changes in gene expression we observed were more proximal to initial patterning events than those previously observed, although we have not yet rigorously addressed whether the marker genes used here are activated as immediate early responses to various factors, except for HoxD1 (Kolm and Sive, 1995) .
Two results obtained in this study are different from those obtained in studies with longer cap culture times. First, we observed that RA did not downregulate expression of otx2 induced by Noggin, in contrast to the sharp inhibition observed when neurula or tailbud stage caps were assayed (Gammill and Sive, 1997) . This suggests that the response to RA is complex and may require intervening steps which had not occurred before caps were harvested at mid-gastrula. Curiously, Cerberus, another BMP antagonist, did allow downregulation of otx2 expression in the presence of RA. Cerberus is known to be a weaker BMP antagonist, and to have Nodal and Wnt antagonizing activities (Piccolo et al., 1999) , which may account for this difference.
Second, we observed that wnt3a alone, or in combination with Noggin, was able to activate expression of both opl (which initially marks the entire neural plate) and the more posterior markers fkh5 and HoxD1. Since the anterior marker otx2 was not activated, our data are thus consistent with the hypothesis that wnts activate posterior and general neural fates. In tailbud stage caps, Wnt3a can ef®ciently posteriorize neural tissue but only in conjunction with a neural inducer such as Noggin (McGrew et al., 1995) . However, Baker et al. (1999) showed that in tailbud stage caps either Wnt8 or Wnt3a alone is able to activate posterior and general neural markers, as well as an anterior ectodermal (cement gland) marker. Part of the differences in these data may re¯ect the speci®c markers used, and also the timing of cap harvest.
3.5. The relationship of the early gastrula A/P pattern to classical models of neural induction How does A/P patterning of the early gastrula Xenopus neurectoderm (summarized in Fig. 10 ) relate to the two classical models of neural induction: Nieuwkoop's twosignal model and the`one-to-one' model of the Spemann school (reviewed in Gamse and Sive, 2000) ? The two-signal model proposed a uniform activating or forebrain-inducing signal, followed by a graded transforming signal which posteriorizes some presumptive forebrain to presumptive hindbrain and spinal cord. In contrast, the one-to-one model proposed that the A/P pattern in the neurectoderm was a re¯ection of existing A/P regionalization in the underlying mesendoderm, with the pattern transferred by qualitatively different signals emanating from each mesendodermal region. Elements of both models are supported by our results and those recently reported in other systems (Gamse and Sive, 2000) .
First, the temporal order of the two-signal model is In a mid-gastrula embryo, a greater A/P pattern exists. In the anterior domain of the future neurectoderm, expression of opl and otx2 is activated or maintained by low concentrations of Noggin, possibly in conjunction with Cerberus. In the middle domain, higher Noggin concentrations alone, or in conjunction with FGF, induce fkh5 expression. In the posterior domain, high Noggin concentrations or Wnt3a activate expression of opl, fkh5 and HoxD1, with suppression of otx2. FGF acts in conjunction with Noggin to activate fkh5 expression. Retinoids (RA) and FGF alone also activate HoxD1 expression (Kolm and Sive, 1995) . Since Wnt3a does not activate otx2 expression, we conclude that it is primarily a posterior neural inducer at this stage of development, and that opl expression is induced in this domain. strongly supported by this study and others, with forebrain fates being induced before more posterior fates (hindbrain and spinal cord) (reviewed in Gamse and Sive, 2000) . However, contrary to the two-signal model, the anterior signal is not uniform in nature. Comparison of the otx2, opl and fkh5 expression patterns to published fate maps (Keller, 1975) suggests that their expression domains indicate a division of the future forebrain, placing them within the`activation' domain. This is supported by the observations that expression of these genes (1) can be activated by Noggin (which only induces anterior fates in animal caps; Lamb et al., 1993) , (2) is induced before a hindbrain-speci®c marker (HoxD1), and (3) is not activated by the posterior inducer RA . Since speci®cation of otx2 expression occurs before that of fkh5, one conclusion from this study is that anterior forebrain fates are induced before more posterior fates. These data suggest that, even within the forebrain ®eld, sequential patterning occurs, and are not consistent with the uniform activation event proposed by Nieuwkoop. Additional recent data corroborate the idea that a complex anterior inducing center(s) exists. The two-signal model implied that anterior tissue needed to passivelỳ escape' posteriorization in order to remain determined as anterior (Eyal-Giladi, 1954; Sive et al., 1989) . However, recent studies in chick (Foley et al., 2000) and mouse (Kimura et al., 2000) suggest that anterior inducing tissue (hypoblast in chick or anterior visceral endoderm in mouse) actively inhibits posteriorization. This action is not a stable induction of anterior fates, as in chick the hypoblast can only transiently induce anterior neural markers (Foley et al., 2000; Streit et al., 2000) . Consistently, we and others (this study; Bouwmeester et al., 1996; Bradley et al., 1996) have found that the Xenopus anterior endoderm, which may be analogous to the anterior hypoblast, alone is not able to induce neural marker expression, but likely synergizes with other tissues to promote anterior fates.
The two-signal model suggested that induction of hindbrain and spinal cord fates occurred through a graded posteriorizing signal. However, evidence for such a graded factor is not compelling in any system (reviewed in Gamse and Sive, 2000) . Rather, discrete inducing centers along the A/P mesendodermal axis acting through different factors (RA, FG, Wnt3a), or combinations of these, are more likely to pattern the neurectoderm, consistent with the one-to-one model. For example, RA acts at the hindbrain level where it is required for normal hindbrain patterning (reviewed in ). FGF appears to act more posteriorly than the hindbrain (reviewed in Gamse and Sive, 2000) , although in chickens, FGF is also required for general neural induction (Streit et al., 2000) .
Future studies will concentrate on the detailed mechanism by which the early A/P neural pattern is generated, including analysis of the in vivo role of putative inducers, and determination of cis-acting promoter sequences which respond to positional information.
Experimental procedures
4.1. Growth, dissection, and culture of embryos and explants Xenopus laevis eggs were collected, fertilized and cultured as described in Sive et al. (1989) . Embryos were staged according to Nieuwkoop and Faber (1994) . For animal caps, late blastula (stage 9±9.5) animal hemisphere ectoderm was isolated and incubated in 1£ modi®ed Barth's saline (MBS) alone, or with other reagents as indicated. For identi®cation of the dorsal side of late blastula embryos, the tip and stain protocol was followed (Peng, 1991) . For ventralization of embryos by UV irradiation, 50±100 embryos were moved into a 50 ml conical plastic tube with 0.1£ MBS and irradiated as described in Sive et al. (2000) . Irradiation was by a hand-held UV lamp (UVP model UVG-11, 254 nm) and was titrated (between 30 and 90 s) for each batch of embryos to give maximal ventralization and minimal death.
For mesoderm/ectoderm conjugates, mesoderm was obtained from stage 11 embryos. Parasagittal cuts were made 308 to each side of the midline. The dorsal ectoderm was peeled off and discarded, starting at the blastocoel. Anterior mesendoderm corresponded to mesendoderm extending anteriorly from the limit of involution to tissue overlying the anterior one-third of the archenteron. Posterior mesendoderm included tissue overlying the posterior onethird of the archenteron. Anterior and posterior mesoderm was removed and stored in 1£ MBS supplemented with 100 mg/ml BSA. Caps were cut from stage 9.5 embryos, and freshly cut caps were conjugated with each anterior or posterior mesodermal piece. Conjugates were aged in 1£ MBS supplemented with 100 mg/ml BSA until control embryos reached stage 11.
Subtractive cloning of fkh5
PCR-based subtractive cloning (Kuo et al., 1998; Patel and Sive, 1996) was used to identify a partial fkh5 cDNA from isolated mid-gastrula (stage 11.5) dorsal ectoderm. A full-length fkh5 cDNA was isolated from a cDNA library prepared from stage 11.5 dorsal ectoderm (C. Nocente and H. Sive, unpublished data). Screening of 750 000 plaques was performed, and two fkh5 clones were obtained, one of 1.8 kb and one of 2.4 kb. Northern blotting showed a native RNA length of approximately 2.5 kb, indicating that the 2.4 kb clone was a full-or nearly full-length cDNA. Conceptual translation of the longest open reading frame of the 2.4 kb clone yielded a 320 aa protein (Fig. 1A) . BLAST searching with the protein sequence revealed high similarity to mouse fkh5 across the entire protein.
Microinjection and factor treatment
Embryos were dejellied in 2% cysteine (pH 8.0) 20±30 min after fertilization, and rinsed in 0.1£ MBS. At the twocell stage, embryos were placed in 1£ MBS 1 4% Ficoll (Sigma) and injected with 20 nl of mRNA in the animal pole. mRNA encoding cerberus, noggin, dickkopf, Wnt3a, XFD, dnWnt8, GFP, or as a control b -globin were injected for factor testing experiments. For Noggin gradient experiments, all embryos were injected with 10 pg total RNA, the balance being made up with globin. After microinjection, embryos recovered for 1±3 h in 1£ MBS 1 4% Ficoll, and were subsequently allowed to develop in 0.1£ MBS 1 1% Ficoll until dissection of caps at stage 9. Caps were allowed to develop to stage 11 in 1£ MBS. For FGF or RA treatment, 50 ng/ml hbFGF (Promega) or 1 mM all-trans RA was added to the 1£ MBS.
In vitro transcription
Capped mRNA was transcribed according to Krieg and Melton (1987) . Templates for sense RNA were as follows: p64TXbM (b-globin) (Krieg and Melton, 1984) ; pCS21 cerberus (Bouwmeester et al., 1996) ; pCS21 xnoggin (gift from Richard Harland); p64T-X11 (Xwnt-11) (Ku and Melton, 1993) ; pSP64T-Wnt3a (Wolda et al., 1993) ; XFD (Amaya et al., 1991) ; pCS21 dnWnt-8 (Hoppler et al., 1996) .
Antisense in situ hybridization probes were labeled with digoxigenin-11-UTP or¯uorescein-12-UTP (Enzo Diagnostics) (Harland, 1991) . Templates for antisense RNA were as follows: pBS-fkh5, BamHI linearized, T7 transcribed; pBS-BMP4, EcoRI linearized, T7 transcribed; pBS-Xhox.lab.1 (HoxD1) (Sive and Cheng, 1991) ; pBSopl 6.11 (Kuo et al., 1998) ; pT7TS-otx2 (Pannese et al., 1995); pSP6-En2 (Hemmati-Brivanlou et al., 1991) ; pXKrox20 (Papalopulu et al., 1991) .
In situ hybridization and sectioning
Whole-mount in situ hybridization was performed on albino embryos as described in Harland (1991) with modi®-cations as described in Kuo et al. (1998) . For sections, two methods were employed. For stage 101, embryos were ®xed for 1 h in 100 mM MOPS ph 7.4, 2 mM EGTA, 1 mM MgSO 4 , 40% paraformaldehyde (MEMPFA), cut in half with an eyebrow knife, re®xed for 1 h, and then subjected to in situ hybridization. For all other stages, embryos were subjected to in situ hybridization, and then embedded in JB4 resin (Polysciences). Sections (8 mm) were cut on a microtome using a dry glass knife, stained with Neutral Red, and mounted in Crystal Mount (Biomeda).
